📣 VC round data is live. Check it out!

4Mass Valuation Multiples

Discover revenue and EBITDA valuation multiples for 4Mass and similar public comparables like Delko, Mundial, Mediterra, Candles Scandinavia and more.

4Mass Overview

About 4Mass

4Mass SA operates in cosmetics industry. The company is engaged in the production and distribution of makeup products. Its brand profile includes Clares, Stylistic, and Palu.


Founded

2009

HQ

Poland

Employees

143

Website

4mass.pl

Sectors

Financials (FY)

Revenue: $30M
EBITDA: $5M

EV

$21M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

4Mass Financials

4Mass reported last fiscal year revenue of $30M and EBITDA of $5M.

In the same fiscal year, 4Mass generated $18M in gross profit, $5M in EBITDA, and $3M in net income.


4Mass P&L

In the most recent fiscal year, 4Mass reported revenue of $30M and EBITDA of $5M.

4Mass is profitable as of last fiscal year, with gross margin of 61%, EBITDA margin of 16%, and net margin of 10%.

See analyst estimates for 4Mass
Last FY202320242025202620272028
Revenue$30M$26M$31M$30M
Gross Profit$18M$16M$19M$18M
Gross Margin61%60%61%61%
EBITDA$5M$7M$6M$5M
EBITDA Margin16%26%21%16%
EBIT Margin13%25%18%13%
Net Profit$3M$5M$5M$3M
Net Margin10%19%16%10%

Financial data powered by Morningstar, Inc.

4Mass Stock Performance

4Mass has current market cap of $25M, and enterprise value of $21M.

Market Cap Evolution


4Mass' stock price is $1.13.

4Mass share price increased by 0.3% in the last 30 days, and decreased by 6.1% in the last year.

4Mass has an EPS (earnings per share) of $0.13.

See more trading valuation data for 4Mass
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$21M$25M-0.1%0.3%-17.3%-6.1%$0.13

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

4Mass Valuation Multiples

4Mass trades at 0.7x EV/Revenue multiple, and 4.4x EV/EBITDA.

See NTM and 2027E valuation multiples for 4Mass

4Mass Financial Valuation Multiples

As of May 20, 2026, 4Mass has market cap of $25M and EV of $21M.

4Mass has a P/E ratio of 8.7x.

Last FY202320242025202620272028
EV/Revenue0.7x0.8x0.7x0.7x
EV/EBITDA4.4x3.1x3.2x4.4x
EV/EBIT5.3x3.1x3.7x5.3x
EV/Gross Profit1.2x1.3x1.1x1.2x
P/E8.7x5.0x5.2x8.7x
EV/FCF4.7x6.0x17.9x4.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified 4Mass Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

4Mass Margins & Growth Rates

In the most recent fiscal year, 4Mass reported gross margin of 61%, EBITDA margin of 16%, and net margin of 10%.

See estimated margins and future growth rates for 4Mass

4Mass Margins

Last FY20242025202720282029
Gross Margin61%61%61%
EBITDA Margin16%21%16%
EBIT Margin13%18%13%
Net Margin10%16%10%
FCF Margin15%4%15%

4Mass Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth17%(4%)
Gross Profit Growth19%(4%)
EBITDA Growth(5%)(26%)
EBIT Growth(16%)(30%)
Net Profit Growth(4%)(40%)
FCF Growth(67%)281%

Data powered by FactSet, Inc. and Morningstar, Inc.

4Mass Operational KPIs

4Mass' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for 4Mass
Last FY202320242025202620272028
Revenue per Employee$0.2M
Opex per Employee$0.1M
Opex to Revenue48%35%43%48%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

4Mass Competitors

4Mass competitors include Delko, Mundial, Mediterra, Candles Scandinavia, Clemondo Group, Harper Hygienics, Miraculum, Lifeclean International, MADARA Cosmetics and Yalco Constantinoy.

Most 4Mass public comparables operate across Home Care.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Delko0.2x5.1x
Mundial0.7x5.6x
Mediterra
Candles Scandinavia1.5x1.2x38.1x19.2x
Clemondo Group0.5x0.5x6.4x6.2x
Harper Hygienics0.5x5.6x
Miraculum0.8x42.4x
Lifeclean International1.5x(3.3x)

This data is available for Pro users. Sign up to see all 4Mass competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About 4Mass

When was 4Mass founded?4Mass was founded in 2009.
Where is 4Mass headquartered?4Mass is headquartered in Poland.
How many employees does 4Mass have?As of today, 4Mass has over 143 employees.
Is 4Mass publicly listed?Yes, 4Mass is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of 4Mass?4Mass trades under 4MS ticker.
When did 4Mass go public?4Mass went public in 2019.
Who are competitors of 4Mass?4Mass main competitors include Delko, Mundial, Mediterra, Candles Scandinavia, Clemondo Group, Harper Hygienics, Miraculum, Lifeclean International, MADARA Cosmetics, Yalco Constantinoy.
What is the current market cap of 4Mass?4Mass' current market cap is $25M.
What is the current revenue of 4Mass?4Mass' last fiscal year revenue is $30M.
What is the current EV/Revenue multiple of 4Mass?Current revenue multiple of 4Mass is 0.7x.
Is 4Mass profitable?No, 4Mass is not profitable.
How many companies 4Mass has acquired to date?4Mass hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies 4Mass has invested to date?4Mass hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to 4Mass

Lists including 4Mass

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial